Introduction
Atrial fibrillation is a common heart rhythm disorder that is expected to rise in the coming years. While lifestyle changes and managing risk factors are important for treatment, there is limited research on how exercise impacts patients with this condition.
About the Study
The Norwegian Exercise in Atrial Fibrillation Trial (NEXAF) aims to explore the effects of a 12-month exercise program on patients who have been inactive and diagnosed with atrial fibrillation.
Study Design
NEXAF is a large trial that randomly assigns participants aged 18-80 with atrial fibrillation to either an exercise program or standard care for one year. The main goals are to measure how much time patients spend in atrial fibrillation and how their quality of life improves.
Ethics Approval
This study has received ethical approval from the Regional Ethics Committee in Mid-Norway.
Measurable Outcomes
Key outcomes include:
- Time spent in atrial fibrillation
- Quality of life improvements
Practical Goals for Clinics and Patients
Clinics and patients can set clear goals based on the study’s findings to improve health management in atrial fibrillation.
AI Tools for Clinical Needs
Choose AI solutions that are specifically designed to assist with the management of atrial fibrillation and related health outcomes.
Implementation Steps
Start with a pilot project to track results using AI tools, ensuring that real-world impacts are measured alongside research findings.
Contact Us
For more information on AI solutions in medical management, please reach out:
- Telegram: https://t.me/itinai
- X: https://x.com/vlruso
- LinkedIn: https://www.linkedin.com/company/itinai/
